Etiology and management of hypertension in chronic kidney disease

被引：13

作者：

Andersen, MJ

Agarwal, R

机构：

[1] Indiana Univ, Sch Med, Dept Med, Div Nephrol, Indianapolis, IN 46202 USA

[2] Richard L Roudebush Vet Affairs Med Ctr, Indianapolis, IN 46202 USA

来源：

MEDICAL CLINICS OF NORTH AMERICA | 2005年 / 89卷 / 03期

基金：

美国国家卫生研究院;

关键词：

D O I：

10.1016/j.mcna.2004.12.001

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

The kidneys are vital in the pathogenesis of hypertension and are also pathologically affected by the presence of hypertension. The prevalence of hypertension in chronic kidney disease (CKD) depends on age, the severity of renal failure, and proteinuria. The intricate and inextricable relationship between CKD and hypertension seems to cause cardiovascular disease that has assumed epidemic proportions. This article discusses the etiology and treatment of hypertension in CKD so that it can be better controlled.

引用

收藏

页码：525 / +

页数：24

相关论文

共 164 条

[1] Systolic hypertension in hemodialysis patients [J].

Agarwal, R .

SEMINARS IN DIALYSIS, 2003, 16 (03) :208-213

[2] Proinflammatory effects of oxidative stress in chronic kidney disease: role of additional angiotensin II blockade [J].

Agarwal, R .

AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 2003, 284 (04) :F863-F869

[3] Add-on angiotensin II receptor blockade lowers urinary transforming growth factor-β levels [J].

Agarwal, R ;

Siva, S ;

Dunn, SR ;

Sharma, K .

AMERICAN JOURNAL OF KIDNEY DISEASES, 2002, 39 (03) :486-492

[4] Prevalence, treatment, and control of hypertension in chronic hemodialysis patients in the United States [J].

Agarwal, R ;

Nissenson, AR ;

Batlle, D ;

Coyne, DW ;

Trout, JR ;

Warnock, DG .

AMERICAN JOURNAL OF MEDICINE, 2003, 115 (04) :291-297

[5]

Agarwal R, 2001, KIDNEY INT, V59, P2282, DOI 10.1046/j.1523-1755.2001.0590062282.x

[6] Protective effects of dietary L-arginine supplementation on chronic cyclosporine nephrotoxicity [J].

Andoh, TF ;

Gardner, MP ;

Bennett, WM .

TRANSPLANTATION, 1997, 64 (09) :1236-1240

[7] Chronic cyclosporine nephrotoxicity [J].

Andoh, TF ;

Bennett, WM .

CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION, 1998, 7 (03) :265-270

[8] Beyond (or back to) traditional risk factors: Preventing cardiovascular disease in patients with chronic kidney disease [J].

Appel, LJ .

ANNALS OF INTERNAL MEDICINE, 2004, 140 (01) :60-61

[9] NITRIC-OXIDE AND CGMP CAUSE VASORELAXATION BY ACTIVATION OF A CHARYBDOTOXIN-SENSITIVE K-CHANNEL BY CGMP-DEPENDENT PROTEIN-KINASE [J].

ARCHER, SL ;

HUANG, JMC ;

HAMPL, V ;

NELSON, DP ;

SHULTZ, PJ ;

WEIR, EK .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (16) :7583-7587

[10] AUTOMATED AMBULATORY BLOOD-PRESSURE AND SELF-MEASURED BLOOD-PRESSURE MONITORING DEVICES - THEIR ROLE IN THE DIAGNOSIS AND MANAGEMENT OF HYPERTENSION [J].

AUDET, AM .

ANNALS OF INTERNAL MEDICINE, 1993, 118 (11) :889-892

← 1 2 3 4 5 6 7 8 9 10 →